News Focus
News Focus
Post# of 9487
Next 10
Followers 5
Posts 901
Boards Moderated 0
Alias Born 07/25/2005

Re: None

Tuesday, 01/19/2010 9:26:59 AM

Tuesday, January 19, 2010 9:26:59 AM

Post# of 9487
GenVec will collaborate with Novartis AG (NVS) in developing treatments for hearing loss and balance disorders, saying it could receive as much as $213.6 million in upfront and milestone payments from the partnership. GenVec's shares jumped 20% to $2.08

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today